Celyad Oncology

celyad.com

1345 Avenue of the Americas

New York, NY 10105

Company Info

Year Established
2007

Ticker
CLYY

Exchange
OTCMKTS

Contacts

Michel Lussier
Interim CEO

Eytan Breman
Director, R&D

Company Description

Celyad Oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells.